Sunday, October 17, 2021

Covaxin gets nod for trial of booster shot – ET HealthWorld


Hyderabad: Indigenous Covid-19 vaccine Covaxin will now be tested for a booster dose, to be given six months after the second jab.

Bharat Biotech has received the approval of the subject expert committee (SEC) for this. The SEC, which advises the Drugs Controller General of India (DCGI), has recommended that Bharat Biotech conduct the booster dose study only on Phase II trial participants after they have taken 6mcg of Covaxin.

The committee has also directed the company to follow up the subjects for at least for six months after the third dose is administered.

The SEC’s nod for the booster dose study came after Bharat Biotech requested amendments in the approved Phase II trial protocol to allow for administration of a booster dose six months after the second dose.

Follow and connect with us on , Facebook, Linkedin





Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...